Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May 8:22:e931616.
doi: 10.12659/AJCR.931616.

Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report

Affiliations
Case Reports

Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report

Julie Byler et al. Am J Case Rep. .

Abstract

BACKGROUND Rhabdomyolysis occurs when muscle injury leads to the release of muscle cell constituents into circulation, often leading to significant systemic complications. There are many causes of rhabdomyolysis, and the etiology is often multifactorial or unclear. Current data suggest that acute COVID-19 may cause muscle injury that can lead to rhabdomyolysis, particularly in cases of severe illness requiring prolonged hospitalization; however, data on the long-term effects of COVID-19 on the musculoskeletal system are lacking. CASE REPORT We present a case of a woman with generalized weakness 1 week following discharge from the hospital after a prolonged admission for severe COVID-19. She was found to have acute kidney injury and elevated creatine kinase (CK) of 1775 U/L (normal 36-234 U/L). Her home medications, including her statin, were held, but her CK continued to rise, peaking at 15 085 U/L, and she developed renal failure necessitating renal replacement therapy. A thorough work-up for the underlying etiology of her rhabdomyolysis was pursued, including testing for autoimmune myositis, statin-associated necrotizing autoimmune myositis, and a muscle biopsy, which were all unrevealing. Ultimately, the patient's rhabdomyolysis was determined to likely be secondary to a post-viral myopathy from COVID-19. A toxic myopathy from medication use or a delayed critical illness myopathy from her recent prolonged hospitalization could have also contributed. CONCLUSIONS This case highlights the wide differential diagnosis of rhabdomyolysis in the setting of recent COVID-19 and prolonged hospitalization. It demonstrates the possibility that muscle injury and resultant rhabdomyolysis may be a late complication of COVID-19 that is not yet fully described in the literature.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Conflicts of Interest

None.

Figures

Figure 1.
Figure 1.
Graph illustrating patient’s creatinine and creatine kinase levels in the context of her hospital course and time from SARSCoV-2 infection.
Figure 2.
Figure 2.
(A, B) MRI bilateral quadriceps showing diffusely increased T2 signal throughout the visualized musculature, with fluid present along the deep rectus femoris, consistent with diffuse bilateral thigh myositis and extensive subcutaneous edema without organized fluid collection.

Similar articles

Cited by

References

    1. Fadila M, Wool K. Rhabdomyolysis secondary to influenza A infection: A case report and review of the literature. N Am J Med Sci. 2015;7(3):122–24. - PMC - PubMed
    1. Singh U, Scheld W. Infectious etiologies of rhabdomyolysis: Three case reports and review. Clin Infect Dis. 1996;22(4):642–49. - PubMed
    1. Suwanwongse K, Shabarek N. Rhabdomyolysis as a presentation of 2019 novel coronavirus disease. Cureus. 2020;12(4):e7561. - PMC - PubMed
    1. Rivas-García S, Bernal J, Bachiller-Corral J. Rhabdomyolysis as the main manifestation of coronavirus disease 2019. Rheumatology. 2020;59(8):2174–76. - PMC - PubMed
    1. Husain R, Corcuera-Solana I, Dayan E, et al. Rhabdomyolysis as a manifestation of a severe case of COVID-19: A case report. Radiol Case Rep. 2020;15(9):1633–37. - PMC - PubMed

Publication types